Related Experiment Video
Updated: Mar 26, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
[Indications and results of endovascular therapy of critical limb ischemia]
A Zimmermann1, U Ludwig1, H-H Eckstein2
1Klinik und Poliklinik für Vaskuläre und Endovaskuläre Chirurgie, Klinikum rechts der Isar, Technische Universität München, Ismaninger Str. 22, 81675, München, Deutschland.
Insights
Endovascular therapy is now a viable alternative to bypass surgery for critical limb ischemia (CLI), offering comparable outcomes with fewer complications. This approach is increasingly recommended as a first-line treatment in experienced centers.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Artery Disease
Background:
- Critical limb ischemia (CLI) is a severe peripheral artery occlusive disease with high rates of amputation, morbidity, and mortality.
- Revascularization is crucial for limb salvage in CLI patients.
Purpose of the Study:
- To review the indications and outcomes of endovascular therapy for CLI.
- To compare endovascular treatment with traditional bypass surgery.
Main Methods:
- Literature search for comparative studies of endovascular vs. surgical therapy.
- Inclusion of observational studies on endovascular techniques.
Main Results:
- The BASIL trial indicates endovascular therapy is equivalent to surgery for CLI when a suitable vein is available and life expectancy exceeds 2 years.
- Meta-analysis confirms equivalence between operative and endovascular treatments for CLI.
Conclusions:
- CLI poses significant mortality and morbidity risks.
- Endovascular-first strategy is justified in most CLI patients due to comparable amputation-free survival and lower complication rates.
Background:
Critical limb ischemia (CLI) is the most severe form of peripheral artery occlusive disease and is characterized by high amputation, morbidity and mortality rates. Therefore, revascularization is the essential step in therapy for retention of the affected limb.
Objectives:
Although for a long time bypass surgery represented the gold standard in the treatment of CLI, in recent years there has been a disproportionate increase of endovascular treatment despite the lack of level-data. In this review the indications and results of endovascular therapy of CLI are presented on the basis of published data.
Methods:
A literature search was carried out to identify publications that compared the results of endovascular and surgical therapy as well as observational studies about different endovascular techniques.
Results:
The BASIL study provided the highest quality data comparing endovascular and surgical treatment of CLI. The long-term data of the BASIL trial showed that apart from patients with a suitable vein and a life expectancy of more than 2 years, first line endovascular therapy is equivalent to surgical treatment. The equivalence could also be demonstrated in a meta-analysis comparing operative and endovascular treatment of CLI.
Conclusion:
The CLI is a disease with high mortality and morbidity risks. Due to the comparable amputation-free survival times with lower complication rates in the published data, in most patients an endovascular first strategy in experienced centers can be justified.
More Related Videos
07:48Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation